Literature DB >> 8841419

Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation.

C E Stewart1, P L James, M E Fant, P Rotwein.   

Abstract

Previous studies have shown that exogenous insulin-like growth factors (IGFs) can stimulate the terminal differentiation of skeletal myoblasts in culture and have established a correlation between the rate and the extent of IGF-II secretion by muscle cell lines and the rate of biochemical and morphological differentiation. To investigate the hypothesis that autocrine secretion of IGF-II plays a critical role in stimulating spontaneous myogenic differentiation in vitro, we have established C2 muscle cell lines that stably express a mouse IGF-II cDNA under control of the strong, constitutively active Moloney sarcoma virus promoter, enabling us to study directly the effects of IGF-II overproduction. Similar to observations with other muscle cell lines, IGF-II overexpressing myoblasts proliferated normally in growth medium containing 20% fetal serum, but they underwent enhanced differentiation compared with controls when incubated in low-serum differentiation medium. Accelerated differentiation of IGF-II overexpressing C2 cells was preceded by the rapid induction of myogenin mRNA and protein expression (within 1 h, compared with 24-48 h in controls) and was accompanied by an enhanced proportion of the retinoblastoma protein in an underphosphrylated and potentially active form, by a marked increase in activity of the muscle-specific enzyme, creatine phosphokinase, by extensive myotube formation by 48 h, and by elevated secretion of IGF binding protein-5 when compared with controls. These results confirm a role for IGF-II as an autocrine/paracrine differentiation factor for skeletal myoblasts, and they define a model cell system that will be useful in determining the biochemical mechanisms of IGF action in cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841419     DOI: 10.1002/(SICI)1097-4652(199610)169:1<23::AID-JCP3>3.0.CO;2-G

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  24 in total

1.  Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.

Authors:  M A Lawlor; X Feng; D R Everding; K Sieger; C E Stewart; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis.

Authors:  Ramon C J Langen; Annemie M W J Schols; Marco C J M Kelders; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Mar-Apr       Impact factor: 2.416

4.  JAK2/STAT2/STAT3 are required for myogenic differentiation.

Authors:  Kepeng Wang; Chihao Wang; Fang Xiao; Haixia Wang; Zhenguo Wu
Journal:  J Biol Chem       Date:  2008-10-02       Impact factor: 5.157

5.  Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways.

Authors:  Hongxia Ren; Domenico Accili; Cunming Duan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

6.  Long range interactions regulate Igf2 gene transcription during skeletal muscle differentiation.

Authors:  Damir T Alzhanov; Stephanie F McInerney; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

7.  Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.

Authors:  Elizabeth M Wilson; Jolana Tureckova; Peter Rotwein
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

8.  MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2.

Authors:  Emma J Carter; Ruth A Cosgrove; Ivelisse Gonzalez; Joan H Eisemann; Fiona A Lovett; Laura J Cobb; Jennifer M Pell
Journal:  J Cell Sci       Date:  2009-08-04       Impact factor: 5.285

9.  Bayesian Modeling Identifies PLAG1 as a Key Regulator of Proliferation and Survival in Rhabdomyosarcoma Cells.

Authors:  Yanbin Zheng; Lin Xu; Mohammed Hassan; Xiaoyun Zhou; Qinbo Zhou; Dinesh Rakheja; Stephen X Skapek
Journal:  Mol Cancer Res       Date:  2019-11-22       Impact factor: 5.852

10.  Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.

Authors:  Massimo Scacchi; Leila Danesi; Agnese Cattaneo; Giovanna Sciortino; Raffaella Radin; Alberto Giacinto Ambrogio; Giovanni Vitale; Emanuela D'Angelo; Nadia Mirra; Laura Zanaboni; Marica Arvigo; Mara Boschetti; Diego Ferone; Paolo Marzullo; Marina Baldini; Elena Cassinerio; Maria Domenica Cappellini; Luca Persani; Francesco Cavagnini
Journal:  Endocrine       Date:  2016-01-29       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.